BioMarin Treatment Gets Special FDA Status
BioMarin Pharmaceutical autoimmune disorder treatment gets special FDA status
09:27AM 11/30/09
BioMarin 3Q Profit Jumps Improved Drug Sales
BioMarin says product revenue improved in 3Q, projects narrower loss for full year
05:52PM 10/28/09
The Bull and Bear Story on GTx's Pending Drug Decision: BioBuzz
Acapodene faces an FDA decision Friday.
10:56AM 10/27/09
Big-Cap Biotech Worries Lead Sector Down: BioBuzz
Getting answers to why biotech is underperforming.
07:37AM 10/27/09
Citi Analyst Reaffirms BioMarin As A 'buy'
Citi analyst reaffirms BioMarin 'buy,' raises price target citing outlook for product pipeline
12:22PM 09/17/09
'Fast Money' Portfolios of the Week
Here's what the 'Fast Money' crew has been talking about lately.
12:14PM 09/17/09
Psst... These Drug Firms Are Getting Bought: BioBuzz
Big Pharma is seeking deals with biotech, specialty pharma, analyst says
07:15AM 09/17/09
'Mad Money Lightning Round': Bank With Banco Santander
Cramer says it's one of the finest banks in the world.
07:24PM 09/16/09
Cramer's 'Mad Money' Recap: Recovery Kicks Into Gear (Final)
Cramer says the growing demand for PVCs, plastics and aluminum indicate the recovery is underway. Click for news from Jim Cramer.
06:39PM 09/16/09
Sector Snap: Analyst Keeps Positive Biotech View
A Morgan Joseph analyst maintains positive outlooks for Amgen, ImmunoGen, and Isis
12:37PM 09/08/09
Ratings Changes: Cablevision, Eaton Vance
TheStreet.com Ratings upgraded cable-TV provider Cablevision and asset manager Eaton Vance.
01:00AM 08/05/09
Odds, Analaysts Against Human Genome's Lupus Drug
Human Genome's drug Benlysta provokes nearly universal negativity among analysts.
10:37AM 07/15/09
Short-Squeeze Opportunities in Biotech
These heavily shorted biotech stocks could surge higher on any positive catalyst.
12:55PM 07/09/09
Genzyme Shuts Down Facility After Detecting Virus
Genzyme shuts down facility to clean up virus that has been slowing down production
11:49AM 06/16/09



Connect with TheStreet